Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion type Assertion NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_head.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion description "[Individuals carrying NAT1wt/*10 and NAT1*10/*10 showed higher relative risks of bladder cancer (OR = 2.8, 95% CI = 0.8-10.1 and OR = 2.2, 95% CI = 0.6-8.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion evidence source_evidence_literature NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion SIO_000772 16003747 NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion wasDerivedFrom befree-2016 NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.
- NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_assertion wasGeneratedBy ECO_0000203 NP503056.RAtDsNFdeFhQg9KUIpbz_FdAMa_Iz1E4dsP4d-Dy_z9SY130_provenance.